Green Plains vs Westlake Chemical Partners LP
GPRE and WLKP side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How GPRE and WLKP compare
Green Plains is the larger company, worth 1.2 times as much as Westlake Chemical Partners LP ($880M against $753M).
Westlake Chemical Partners LP grew revenue faster over the last twelve months (12.1% versus −19.1% for Green Plains).
Green Plains keeps more of each dollar of sales as profit, with a net margin of 10.9% compared with 4.7% at Westlake Chemical Partners LP.
Westlake Chemical Partners LP pays a dividend yielding 6.6%; Green Plains does not pay one.
Green Plains scores higher on the StockData Score (13 against 12 for Westlake Chemical Partners LP), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | GPRE | WLKP |
|---|---|---|
| Size and price | ||
| Market cap | $880M | $753M |
| Share price | $12.56 | $21.35 |
| Change, 1 year | 29.6% | 15.2% |
| Change, 5 years | −67.1% | −11.9% |
| Beta (5Y) | −0.60 | 0.16 |
| Employees | 642 | – |
| StockData Score | ||
| Total score | 13 (better) | 12 |
| Valuation score | 5 (better) | 3 |
| Growth score | 1 | 2 (better) |
| Performance score | 4 (better) | 1 |
| Health score | 3 | 3 |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | 5.1× | – |
| P/S | 0.5× (better) | 0.6× |
| P/B | 0.9× | – |
| EV/EBITDA | 4.6× | 1.4× (better) |
| P/FCF | 11.0× | 1.8× (better) |
| FCF yield | 9.1% | 54.4% (better) |
| Fair value | $64.31 | $195.84 |
| Margin of safety | 80.5% | 89.1% (better) |
| Growth | ||
| Revenue growth (TTM) | −19.1% | 12.1% (better) |
| Revenue growth, 5Y average | 1.7% | 3.8% (better) |
| Net income growth (TTM) | – | 9.4% |
| Profitability | ||
| Gross margin | 19.7% | 31.2% (better) |
| Operating margin | 9.3% | 28.8% (better) |
| Net margin | 10.9% (better) | 4.7% |
| FCF margin | 4.4% | 33.1% (better) |
| Return on equity | 22.9% | – |
| Return on invested capital | 15.4% | – |
| Financial health | ||
| Debt / equity | 0.50 | – |
| Net debt / EBITDA | 1.21 | – |
| Interest coverage | 5.0× | 16.4× (better) |
| Current ratio | 2.31 | 3.44 (better) |
| Altman Z-score | 2.13 | 3.10 (better) |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Dividend yield | – | 6.6% |
| Shareholder yield | 0.00% | 6.6% (better) |
| Ownership | ||
| Held by institutions | 111% | 29.1% |
| Held by insiders | 18.1% | 44.3% |
| Insider net buying, 12 months | $101K | – |
| Short interest, % of float | 22.7% | 0.75% |
Go deeper
- GPRE stock overview
- GPRE income statement
- GPRE valuation and score
- WLKP stock overview
- WLKP income statement
- WLKP valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.